Ye Yang

Ye Yang

Auto-generated profile, based on publicly available information

Ye Yang

First Affiliated Hospital of Sun Yat-sen University 3 Guangzhou

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2026 in Cancer Discovery
Verified
Journal Article
Open access
ZCZhihang Chen
Zhihang Chen
XRXiaoxue Ren
Xiaoxue Ren
YZYifan Zhang
Yifan Zhang
YKYoumei Kang
Youmei Kang
YYYe Yang
Ye Yang
MKMing Kuang
Ming Kuang
Neutrophils are major players in innate immune immunity. However, their landscape and functions in colorectal cancer liver metastasis (CRLM) remain poorly understood. Here, using single-cell RNA sequencing and spatial-enhanced-resolution-omics-sequencing (Stereo-seq), we provide a comprehensive transcriptional landscape of tumor-associated neutrophils (TANs) in CRLM. Our analysis reveals that a terminally differentiated pro-tumor neutrophils subset (TAN1), characterized by a glycolysis signature and a senescent phenotype, is significantly enriched in liver metastasis and associated with poor prognosis. Mechanistically, TAN1 arises from other TAN subsets through the upregulation of BHLHE40, driven by glucose deprivation in the metastatic microenvironment. Functionally, TAN1 promotes angiogenesis via VEGFA and recruits immunosuppressive macrophages through potential CCL3L1-CCR1 signaling, thereby fostering an angiogenic immunosuppressive niche. As a result, neutrophil-specific knockout of Bhlhe40 in mice significantly promotes anti-tumor immunity and suppresses tumor growth. In sum, our data uncover the critical role of BHLHE40+ senescent-like neutrophils in shaping the immunosuppressive microenvironment of CRLM.

1 October 2026
Verified
Other
Open access
PDF file
ZCZhihang Chen
Zhihang Chen
XRXiaoxue Ren
Xiaoxue Ren
YZYifan Zhang
Yifan Zhang
YKYoumei Kang
Youmei Kang
YYYe Yang
Ye Yang
MKMing Kuang
Ming Kuang
Table S4. Schedule of antibodies and fluorophores Opal for mIHC.

1 October 2026
Verified
Other
Open access
PDF file
ZCZhihang Chen
Zhihang Chen
XRXiaoxue Ren
Xiaoxue Ren
YZYifan Zhang
Yifan Zhang
YKYoumei Kang
Youmei Kang
YYYe Yang
Ye Yang
MKMing Kuang
Ming Kuang
Table S2. Clinicopathologic Characteristics of the patients in cohort 2, related to Figure 2.

1 October 2026
Verified
Other
Open access
PDF file
ZCZhihang Chen
Zhihang Chen
XRXiaoxue Ren
Xiaoxue Ren
YZYifan Zhang
Yifan Zhang
YKYoumei Kang
Youmei Kang
YYYe Yang
Ye Yang
MKMing Kuang
Ming Kuang
Table S1. Clinicopathologic Characteristics of the patients in cohort 1.

1 October 2026
Verified
Other
Open access
PDF file
ZCZhihang Chen
Zhihang Chen
XRXiaoxue Ren
Xiaoxue Ren
YZYifan Zhang
Yifan Zhang
YKYoumei Kang
Youmei Kang
YYYe Yang
Ye Yang
MKMing Kuang
Ming Kuang
Figure S6. Analysis of BHLHE40 binding and hypoxia/glycolysis signature in neutrophils from CRLM.

1 October 2026
Verified
Other
Open access
PDF file
ZCZhihang Chen
Zhihang Chen
XRXiaoxue Ren
Xiaoxue Ren
YZYifan Zhang
Yifan Zhang
YKYoumei Kang
Youmei Kang
YYYe Yang
Ye Yang
MKMing Kuang
Ming Kuang
Figure S4. Localization of TAN subsets in liver metastasis.